(NASDAQ: BNGO) Bionano Genomics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 34.66%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 55.82%.
Bionano Genomics's earnings in 2025 is -$74,330,000.On average, 1 Wall Street analyst forecast BNGO's earnings for 2025 to be -$30,286,070, with the lowest BNGO earnings forecast at -$30,286,070, and the highest BNGO earnings forecast at -$30,286,070.
In 2026, BNGO is forecast to generate -$22,000,700 in earnings, with the lowest earnings forecast at -$22,000,700 and the highest earnings forecast at -$22,000,700.